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We found conditions to obtain the Leu-169+Arg mutant of human ferritin H chain in a stable and non-assembled state. The protein obtained 
is an oligomer of subunits with a high degree of structured conformation, and when concentrated it re-assembles into ferritin cages. Functional 
studies showed that (i) it promotes iron oxidation like the assembled ferritin, but at slower rate, (ii) it is readily precipitated by the oxidised iron 
unless apotransferrin or L-chain ferritin are added to sequester Fe(II1). The results confirm that ferroxidase activity is located within the H-chain, 
and indicate that the cages of the fully assembled ferritins are important not only in maintaining iron in a soluble form, but also in eliciting the 
activity of the ferroxidase centres. 
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1. INTRODUCTION 
Ferritin is an almost spherical iron storage protein 
made from 24 subunits. Each subunit is folded into a 
4-helical bundle conformation with a long loop connect- 
ing helices B and C. In most vertebrates the ferritins are 
composed of various proportions of two subunit types, 
H- and L-chains, genetically distinct but with about 
50% sequence identity [1,2]. Studies of the recombinant 
homopolymers of human H- and L-type chains and of 
some variants indicated that in vitro the H-ferritin oxi- 
dises iron at rates several fold faster than the L-ferritin 
[3,4], and that L-ferritin appears to induce iron mineral- 
ization with higher efficiency than the H-ferritin [5]. 
Crystallographic studies identified a ferroxidase centre 
inside the protein shell of the H-chain involving two 
metal binding sites, A and B, only 3 A apart [6,7]. The 
two sites involve residues Glu-27, Glu-61, Glu-62, His- 
65 and Glu-107 as ligands. Glu-27, Glu-62 and His-65 
are substituted in the L-chain and it lacks ferroxidase 
activity [3,4], and so does the H-chain mutant in which 
Glu-62 and His-65 are artificially substituted [7]. 
The mechanism of ferritin iron uptake has not been 
completely clarified and it appears to involve an inter- 
play between the ferroxidase centres and the cavity that 
accommodates the iron core [5]. Ferritin cages without 
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ferroxidase centres were shown to take up iron, albeit 
slowly [8]. In contrast, single subunits or incomplete 
shells with ferroxidase centres have not been studied. 
Cavities are made by the assembly of 24 subunits, while 
the ferroxidase centres are expected to be made by the 
coming together of the H-chain ligands in the folding 
into the 4-helix bundle [6]. In principle, it is possible to 
have ferroxidase centres in folded but unassembled sub- 
units. However, assembly interactions are strong, and 
disruption of ferritin quaternary structure usually yields 
unfolded peptides [9, lo]. 
We have previously shown that assembly interactions 
of H ferritin can be weakened by site-directed mut- 
agenesis without modifying ferroxidase activity [lo]. 
Here we show that renaturation of the H-chain variant, 
Leu- 169+Arg, yields stable subunit oligomers (here re- 
ferred to as non-assembled ferritin) which retain a high 
degree of structured conformation. Functional studies 
show that (i) the subunits have ferroxidase activity, but 
lower than in the assembled cages, (ii) they are precipi- 
tated by the hydrolysis of the oxidised iron, unless iron 
binding proteins are added to the reaction mixture, (iii) 
L-chain homopolymers act as efficient Fe(II1) binding 
proteins. It is concluded that the presence of fully as- 
sembled ferritin cages is important for the full activity 
of the ferroxidase centres. 
2. MATERIALS AND METHODS 
Production of the complete and correct sequences of human ferritin 
H- and L-chains from E. coli strains has been described [4,11]. The 
H-ferritin variant, Leu-169-+Arg, is described in [10,12,13]. Expres- 
sion, purification and apoferritin preparation were performed as de- 
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scribed in [5]. All ferritins were electrophoretically pure, and treated 
for iron removal before functional studies. Protein concentration was 
determined with BCA reagent (Pierce, Rockford, IL) using bovine 
serum albumin as a standard. When required, the samples were con- 
centrated by a membrane ultra-filtration system (Amicon, Grace, 
Italy). 
Far UV CD spectra were collected as described in [lo]. Fluorescence 
spectra were collected with a Kontron SFM 25 spectrofluorimeter 
with an excitation window of 5 nm and an emission window of 10 nm. 
Apoferritins were denatured by incubation in 6 M GdnHCl, 0.1 M 
HEPES buffer, pH 3.5. Proteins were renatured by IO-fold dilution in 
0.1 M HEPES buffer, pH 7.0, with 1 mM DTT. The conformational 
status of ferritin was derived from the ellipticity values at 222 nm and 
from fluorescence spectra with an excitation at 295 mn [14]. Fluores- 
cence spectra were analysed for the excitation maxima and for the 
ratios of the emission at 354 nm and 327 nm, the maxima of the 
denatured and assembled states, respectively [14]. Gel-filtration exper- 
iments were performed on a Superose 12 FPLC column (Pharmacia, 
Biothec, Italy), equilibrated with 20 mM Tris, pH 7.4, 0.15 M NaCl. 
Iron oxidation was started by adding the appropriate amount of 
Fe(II), as a freshly prepared 10 mM solution of ferrous ammonium 
sulphate in water, to iron-free assembled or non-assembled apofer- 
ritins in 0.1 M HEPES buffer, pH 7.0, to give a final concentration 
of 0.1 mM Fe(I1). Iron oxidation was monitored either by the disap- 
pearance of Fe(I1) with a discontinuous assay as described in Treffry 
et al. [15] or by the increase in optical reading at 310 nm [3]. Ferrox- 
idase activity was also monitored using ovotransferrin (Diarconal, 
Recordati, Italy) as the acceptor of Fe(II1) as described in [3,16]. 
3. RESULTS 
3.1. Renaturation of the H-chain mutant Leu-169+Arg 
We analysed the renaturation conditions of the H- 
chain mutant Leu-169+Arg, which is very much less 
stable than the H-chain wild-type [10,13]. The protein 
was denatured in 6 M GdnHCl, pH 3.5, and renatured 
by diluting it in buffer at pH 7.0 to a final concentration 
of 50-250 ,@ml [lo]. Electrophoretic analyses showed 
that the renaturation product of Leu-169+Arg was a 
single species with a faster mobility than the 24-mer, 
while rHF re-assembled in ferritin cages (Fig. 1, lanes 
1 and 2). Removal of the residual GdnHCl by dialysis 
123 
Fig. 1. Electrophoresis of ferritins (3 pug per well) in a 7.5% poly- 
acrylamide gel, stained with Coomassie blue. Lanes: 1, renatured rHF 
at 0.2 mg/ml; 2, renatured H-chain mutant, Leu-169+Arg, at 0.2 
mg/ml; 3, renatured Leu-169-+Arg concentrated to 1.5 mg/ml. The 
arrows indicate the mobility of the assembled ferritin (top) and of the 
had no effect on the renaturation product of Leu- 
169+Arg, but concentration to 1.5 mg/ml by mem- 
brane ultra filtration induced protein assembly with no 
significant formation of aggregates (Fig. 1, lane 3). We 
found that Leu-169+4rg assembled only at concentra- 
tions above 0.3 mg/ml, and that, once assembled, it 
behaved like the native protein with no evident dissoci- 
ation down to concentrations of 20 &ml (not shown). 
The conformation of the non-assembled Leu- 169+Arg 
was analysed. The tryptophan fluorescence spectra 
(Fig. 2) show that the emission maxima of the native (or 
re-assembled), non-assembled and denatured Leu- 
169+Arg were at 327, 333 and 354 nm, respectively 
(excitation at 295 mn). The ratios of the emissions at 
3541327 nm were 0.64, 0.75 and 1.68, respectively, indi- 
cating that the non-assembled Leu-169+Arg is 90% in 
the folded conformation [lo]. Far UV CD spectra had 
minima at 222 nm, with ellipticity values similar to 
those of the native proteins (not shown). Gel-filtration 
on a calibrated Superose 12 column indicated that the 
non-assembled Leu- 169+Arg has an apparent molecu- 
lar mass of about 65 kDa. These data indicated that the 
non-assembled Leu- 169+Arg is a trimer or a dimer of 
structured subunits. 
3.2. Functional studies of the non-assembled Leu- 
169+Arg 
non-assembled subunit oligomers (bottom). Before functional studies, all the non-assembled Leu- 
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Fig. 2. Emission fluorescence spectra of H-chain mutant, Leu- 
169+Arg, in the assembled (AS), denatured (D) and non-assembled 
(N.AS.) states. Conditions: 50 &ml in 0.1 M HEPES buffer, pH 7.0, 
excitation at 295 nm. 
310 
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Fig. 3. Time-course of iron oxidation. Iron oxidation was followed by 
a discontinuous assay in which the concentration of Fe(I1) was de- 
tected as Feferroxine complex. Conditions: 0.1 M HEPES, pH 7.0, 
0.1 mM ferrous ammonium sulphate, the control contained no pro- 
tein, the assembled Leu-169+Arg (AS) was at 22 &ml, and the 
non-assembled Leu-169+Arg (N.AS.) was at 220 &ml. 
169+Arg samples were analysed on gel electrophoresis 
to verify the absence of assembled species or aggregates. 
The activity was first analysed by monitoring the disap- 
pearance of Fe(I1) by discontinuous assay for the for- 
mation of a Fe(II)-ferrozine complex [15]. The rate of 
iron oxidation induced by 220 pg./ml non-assembled 
Leu- 169+Arg was significantly faster than the protein- 
free control and comparable to that of the 22 ,@ml 
assembled form (Fig. 3). The activities of both forms 
varied linearly with protein concentration (not shown), 
indicating that the specific activity of the non-assembled 
Leu-169+Arg was about 10% of that of the assembled 
form, in this reaction system. 
In other experiments we evaluated the ferroxidase 
activity by monitoring the formation of diferric trans- 
ferrin at 470 nm, as described in [3,16]. In this system 
(AA470 nIlI/ mln ) the activity of the non-assembled Leu- 
169+Arg was about 25% of that of the assembled Leu- 
1693Arg (Fig. 4). 
Next, we monitored iron oxidation as an increase in 
absorbance at 3 10 nm due to the formation of polymeric 
Fe(II1) species (iron cores) [4]. The initial rate of the 
reaction (d A310nm/rmn) of the non-assembled Leu- 
169+Arg at 220 &ml was analogous to that of the 
assembled form at 22 &ml (Fig. 5), but turbidity devel- 
oped after the first min of reaction with the non assem- 
bled protein, due to formation of protein-Fe(II1) aggre- 
gates. Addition of 0.1 PM rLF prevented turbidity 
development, the progression plots reached the ex- 
pected plateau (Fig. 5) and no precipitate was collected 
after the reaction. The initial rate of the reaction was the 
same in the absence and in the presence of rLF. 
4. DISCUSSION 
We show that the H-chain mutant, Leu-169+Arg, 
re-assembles less readily than H- and L-chains, and only 
at higher protein concentrations. The substitution of a 
Leu with an Arg in the strongly hydrophobic region of 
the four-fold axes weakens the inter chain interactions 
responsible for protein assembly and reduces protein 
stability [lo]. More interesting was the finding that 
under conditions in which the mutant does not assem- 
ble, a single species is obtained: a dimer or a trimer of 
structured subunits. This is consistent with data show- 
ing that the subunit dimer is the most populated inter- 
mediate in ferritin renaturation [9] and that subunit 
dimers are in equilibrium with assembled bacterial fer- 
ritins [17]. 
The non-assembled Leu- 169+Arg subunit oligomers 
promote iron oxidation at rates significantly faster than 
protein-free controls, indicating that they have both fer- 
roxidase activity and native-like conformations. This is 
the first direct evidence that the ferroxidase centre is 
located within the subunit and it is in keeping with 
previous suggestions that ferritin subunit folding may 
occur independently of shell assembly [9]. The non-as- 
sembled subunits form insoluble aggregates during re- 
action with Fe(I1) due to the hydrolysis of the oxidised 
iron. This may be expected from a ferritin without a 
cavity, and it was previously observed in a ferritin in 
which the cavity was altered by the deletion of the last 
22 amino acids that form the hydrophobic channels [3]. 
Iron-induced protein aggregation, as monitored by tur- 
bidity development, was prevented by the addition of 
apo-ovotransferrin, which chelates Fe(II1). 
Also rLF added to Leu-169+Arg subunits prevented 
iron-induced protein aggregation, and it incorporated 
the oxidised iron. This appears an interesting model, 
and shows that ferroxidase centres in incomplete shells 
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Fig. 4. Progress curves of the formation of Fe(IIItovotransferrin 
complex. Conditions: 0.2 M sodium acetate, pH 6.0, 50 PM apo- 
ovotransferrin, 0.1 mM ferrous ammonium sulphate, 0.1 mglml of 
Leu-169+Arg in the assembled (AS) and non-assembled (N.AS) 
states. Control in the absence of ferritin. 
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Fig. 5. Progression plots of ferritin iron core formation followed at 310 
nm. Conditions: 0.1 M HEPES, pH 7.0,O.l mM ferrous ammonium 
sulphate, 30°C. Samples: (1) 22 ,&ml of assembled Leu-169+Arg; 
(2) 50 pg/ml of L-homopolymer; (3) 220 ,@ml of non-assembled 
Leu-169+Arg; (4) as in 3 with the addition of 50 @ml of rLF. The 
dashed line is the control in the absence of protein. 
and ferroxidase-free ferritin cavities can cooperate (i.e. 
rLF), one inducing iron oxidation, and the other pre- 
venting protein precipitation, probably by inducing iron 
mineralization. This is in agreement with previous evi- 
dence that some of the iron oxidised by assembled rHF 
is taken up by rLF, and supports the hypothesis that 
rLF binds Fe(II1) [5]. The ferroxidase centres appear to 
be about lo-fold more active in the assembled than in 
the non-assembled ferritins, a difference that may be 
due either to incorrect folding of the ferroxidase centre 
in the non-assembled subunits, or to cage effects. Iron 
probably enters the assembled ferritins via the hydro- 
philic channels where iron binding sites are located 
[6,18], and it mineralises on specific nucleation sites [8]. 
Site-directed modifications of both sites reduce the rate 
of iron oxidation to 15-50% of that of the wild-type 
[8,12]. It is conceivable that in the non-assembled sub- 
units these binding sites are not formed or not func- 
tional, leading to a similar reduction in activity. This 
indicates that the ferritin cages are not simple sinks for 
iron, but that they affect iron oxidation, possibly by 
creating preferential pathways for iron delivery to and 
removal from the ferroxidase centres. 
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